版本:
中国

BRIEF-ProQR announces clearance of IND application to start QR-110 clinical trial

April 27 ProQR Therapeutics NV:

* ProQR Therapeutics NV - top-line trial results are expected in 2018 from trial

* ProQR Therapeutics NV - ProQR can now start clinical development of qr-110 in leber's congenital amaurosis type 10 (LCA 10) patients

* Proqr announces clearance of IND application to start clinical trial for qr-110 in leber’s congenital amaurosis type 10 patients Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐